UK markets close in 1 hour 8 minutes

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
339.49+6.49 (+1.95%)
As of 10:04AM EDT. Market open.
Full screen
Loading interactive chart…
  • Globe Newswire

    Capital Increase in Genmab as a Result of Employee Warrant Exercise

    Company Announcement COPENHAGEN, Denmark; July 5, 2022 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 10,992 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 500 shares at DKK 636.50,491 shares at DKK 815.50,2,750 shares at DKK 939.50,782 shares at DKK 1,025.00,200 shares

  • Globe Newswire

    Transactions in connection with share buy-back program

    Company Announcement COPENHAGEN, Denmark; July 4, 2022 – Genmab A/S (Nasdaq: GMAB). On June 17, 2022 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program. The share buy-back program is expected to be completed no later than August 31, 2022 and comprises up to 370,000 shares. The following transactions were executed under the program from June 27, 2022 to July 1, 2022: No. of s

  • Globe Newswire

    Major Shareholder Announcement

    Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; July 1, 2022 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Wellington Management Group LLP has informed us that, as of June 30, 2022 Wellington Management Group LLP had decreased their holding of shares in Genmab A/S to 4.97% of the share capital and voting rights in Genmab A/S, so that through shares and financial instruments they held the voting r